Earnings Feed
Start Free
Sucampo Pharmaceuticals, Inc.·4

Dec 18, 7:34 PM ET

Sucampo Pharmaceuticals, Inc. 4

4 · Sucampo Pharmaceuticals, Inc. · Filed Dec 18, 2013

Insider Transaction Report

Form 4
Period: 2013-12-16
Sucampo Pharmaceuticals, Inc.SCMP
Dolecek Gayle R
DirectorVP of Research & Development
Transactions
  • Exercise of In-Money

    Employee Stock Option (Right to Buy)

    2013-12-16$8.00/sh−45,000$360,000→ 332,700 total
    Exercise: $4.41From: 2013-06-04Exp: 2021-05-02→ Class A Common Stock (45,000 underlying)
  • Exercise of In-Money

    Class A Common Stock

    2013-12-16$8.00/sh−54,400$435,200→ 332,700 total
  • Exercise of In-Money

    Employee Stock Option (Right to Buy)

    2013-12-16$8.00/sh−9,400$75,200→ 377,700 total
    Exercise: $4.41From: 2012-05-02Exp: 2021-05-02→ Class A Common Stock (9,400 underlying)
Footnotes (1)
  • [F1]The date exercisable for a portion of the stock options is 6/4/2013.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES